Skip to main content

Share story

Security

Web3Auth login remains down as Keplr wallet recovery continues

Web3Auth login remains down as Keplr wallet recovery continues Image: Primary
Web3Auth's login service remains down following a security flaw that enabled theft from some Keplr wallets created with Google or Apple accounts, The Hacker News reported. Web3Auth paused its embedded wallet service and said the issue also affects services used by other companies, naming only Keplr. Web3Auth says it used the attacker's route to move other vulnerable wallets' funds into recovery wallets. Bitquery counted at least $6.01 million transferred from more than 44,000 wallets and corrected its initial characterization of those transfers as theft. Keplr says recovery-phrase and hardware wallets are unaffected. Web3Auth says rescued funds are safe but has not specified how or when users will receive them.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Hacker News and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.